The impact of Ets-1 oncoprotein and human endoglin (CD105) on the recurrence of non-melanoma skin cancers

Chrisostomos Chrisostomidis, Petros Konofaos, Dimitrios Karypidis, Andreas Lazaris, Alkiviadis Kostakis, Othon Papadopoulos

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: The aim of this study was to investigate if the expression of CD105 and Ets-1 was predictive of aggressive biologic behavior of non-melanoma skin cancers (NMSC) and to evaluate indicators of local recurrence. Patients and methods: A total of 144 patients with NMSC were included in the current study. Surgical specimens were independently examined for diagnosis confirmation and immunohistochemical expression of Ets-1 and CD105 by two dermatopathologists. Results: The most common tumor type was basal cell carcinoma (n = 76), followed by squamous cell carcinomas (SCC) (n = 65). The most common anatomic location was the head and neck area (n = 115). The follow-up was >2 years in all examined cases. A statistically significant correlation was found between tumor local recurrence and age (P = 0.03), Ets-1 expression (P < 0.0001) and CD105 expression (P < 0.0001). Conclusions: Our data confirm that both Ets-1 and CD105 show promise as prognostic markers for local recurrence of NMSC. However, this statement is made with caution, and additional studies, with larger populations, are necessary to examine the correlation between these two markers and local recurrence. A better understanding of the pathogenesis of local recurrence in primary NMSC may result in potential therapeutic interventions.

Original languageEnglish (US)
Pages (from-to)989-995
Number of pages7
JournalInternational Journal of Dermatology
Volume54
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

Oncogene Proteins
Skin Neoplasms
Recurrence
Basal Cell Carcinoma
Squamous Cell Carcinoma
Neoplasms
Neck
Head
Endoglin
Population

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

The impact of Ets-1 oncoprotein and human endoglin (CD105) on the recurrence of non-melanoma skin cancers. / Chrisostomidis, Chrisostomos; Konofaos, Petros; Karypidis, Dimitrios; Lazaris, Andreas; Kostakis, Alkiviadis; Papadopoulos, Othon.

In: International Journal of Dermatology, Vol. 54, No. 9, 01.09.2015, p. 989-995.

Research output: Contribution to journalArticle

Chrisostomidis, Chrisostomos ; Konofaos, Petros ; Karypidis, Dimitrios ; Lazaris, Andreas ; Kostakis, Alkiviadis ; Papadopoulos, Othon. / The impact of Ets-1 oncoprotein and human endoglin (CD105) on the recurrence of non-melanoma skin cancers. In: International Journal of Dermatology. 2015 ; Vol. 54, No. 9. pp. 989-995.
@article{e750c34148ec4d80ac82266f82baeb39,
title = "The impact of Ets-1 oncoprotein and human endoglin (CD105) on the recurrence of non-melanoma skin cancers",
abstract = "Background: The aim of this study was to investigate if the expression of CD105 and Ets-1 was predictive of aggressive biologic behavior of non-melanoma skin cancers (NMSC) and to evaluate indicators of local recurrence. Patients and methods: A total of 144 patients with NMSC were included in the current study. Surgical specimens were independently examined for diagnosis confirmation and immunohistochemical expression of Ets-1 and CD105 by two dermatopathologists. Results: The most common tumor type was basal cell carcinoma (n = 76), followed by squamous cell carcinomas (SCC) (n = 65). The most common anatomic location was the head and neck area (n = 115). The follow-up was >2 years in all examined cases. A statistically significant correlation was found between tumor local recurrence and age (P = 0.03), Ets-1 expression (P < 0.0001) and CD105 expression (P < 0.0001). Conclusions: Our data confirm that both Ets-1 and CD105 show promise as prognostic markers for local recurrence of NMSC. However, this statement is made with caution, and additional studies, with larger populations, are necessary to examine the correlation between these two markers and local recurrence. A better understanding of the pathogenesis of local recurrence in primary NMSC may result in potential therapeutic interventions.",
author = "Chrisostomos Chrisostomidis and Petros Konofaos and Dimitrios Karypidis and Andreas Lazaris and Alkiviadis Kostakis and Othon Papadopoulos",
year = "2015",
month = "9",
day = "1",
doi = "10.1111/ijd.12891",
language = "English (US)",
volume = "54",
pages = "989--995",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - The impact of Ets-1 oncoprotein and human endoglin (CD105) on the recurrence of non-melanoma skin cancers

AU - Chrisostomidis, Chrisostomos

AU - Konofaos, Petros

AU - Karypidis, Dimitrios

AU - Lazaris, Andreas

AU - Kostakis, Alkiviadis

AU - Papadopoulos, Othon

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Background: The aim of this study was to investigate if the expression of CD105 and Ets-1 was predictive of aggressive biologic behavior of non-melanoma skin cancers (NMSC) and to evaluate indicators of local recurrence. Patients and methods: A total of 144 patients with NMSC were included in the current study. Surgical specimens were independently examined for diagnosis confirmation and immunohistochemical expression of Ets-1 and CD105 by two dermatopathologists. Results: The most common tumor type was basal cell carcinoma (n = 76), followed by squamous cell carcinomas (SCC) (n = 65). The most common anatomic location was the head and neck area (n = 115). The follow-up was >2 years in all examined cases. A statistically significant correlation was found between tumor local recurrence and age (P = 0.03), Ets-1 expression (P < 0.0001) and CD105 expression (P < 0.0001). Conclusions: Our data confirm that both Ets-1 and CD105 show promise as prognostic markers for local recurrence of NMSC. However, this statement is made with caution, and additional studies, with larger populations, are necessary to examine the correlation between these two markers and local recurrence. A better understanding of the pathogenesis of local recurrence in primary NMSC may result in potential therapeutic interventions.

AB - Background: The aim of this study was to investigate if the expression of CD105 and Ets-1 was predictive of aggressive biologic behavior of non-melanoma skin cancers (NMSC) and to evaluate indicators of local recurrence. Patients and methods: A total of 144 patients with NMSC were included in the current study. Surgical specimens were independently examined for diagnosis confirmation and immunohistochemical expression of Ets-1 and CD105 by two dermatopathologists. Results: The most common tumor type was basal cell carcinoma (n = 76), followed by squamous cell carcinomas (SCC) (n = 65). The most common anatomic location was the head and neck area (n = 115). The follow-up was >2 years in all examined cases. A statistically significant correlation was found between tumor local recurrence and age (P = 0.03), Ets-1 expression (P < 0.0001) and CD105 expression (P < 0.0001). Conclusions: Our data confirm that both Ets-1 and CD105 show promise as prognostic markers for local recurrence of NMSC. However, this statement is made with caution, and additional studies, with larger populations, are necessary to examine the correlation between these two markers and local recurrence. A better understanding of the pathogenesis of local recurrence in primary NMSC may result in potential therapeutic interventions.

UR - http://www.scopus.com/inward/record.url?scp=84939233607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939233607&partnerID=8YFLogxK

U2 - 10.1111/ijd.12891

DO - 10.1111/ijd.12891

M3 - Article

VL - 54

SP - 989

EP - 995

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 9

ER -